Toyota|$17.84 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$27.20 (¥4,312)-1.21%▼ (in JPY terms)
SoftBank|$19.08 (¥3,025)-14.48%▼ (in JPY terms)
MUFG|$19.08 (¥3,024)-5.41%▼ (in JPY terms)
Keyence|$88.48 (¥14,025)-4.53%▼ (in JPY terms)
Nintendo|$55.72 (¥8,832)-5.09%▼ (in JPY terms)
NTT|$1.06 (¥168)-0.71%▼ (in JPY terms)
Takeda|$43.99 (¥6,973)+0.33%▲ (in JPY terms)
Tokyo Electron|$52.42 (¥8,309)-7.06%▼ (in JPY terms)
Recruit|$106.21 (¥16,835)-5.50%▼ (in JPY terms)
ITOCHU|$14.18 (¥2,248)-1.88%▼ (in JPY terms)
Honda|$10.96 (¥1,737)-2.99%▼ (in JPY terms)
Shin-Etsu|$33.04 (¥5,237)-5.28%▼ (in JPY terms)
Tokio Marine|$3.64 (¥578)+2.03%▲ (in JPY terms)
Fast Retailing|$518.70 (¥82,220)-1.38%▼ (in JPY terms)
Toyota|$17.84 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$27.20 (¥4,312)-1.21%▼ (in JPY terms)
SoftBank|$19.08 (¥3,025)-14.48%▼ (in JPY terms)
MUFG|$19.08 (¥3,024)-5.41%▼ (in JPY terms)
Keyence|$88.48 (¥14,025)-4.53%▼ (in JPY terms)
Nintendo|$55.72 (¥8,832)-5.09%▼ (in JPY terms)
NTT|$1.06 (¥168)-0.71%▼ (in JPY terms)
Takeda|$43.99 (¥6,973)+0.33%▲ (in JPY terms)
Tokyo Electron|$52.42 (¥8,309)-7.06%▼ (in JPY terms)
Recruit|$106.21 (¥16,835)-5.50%▼ (in JPY terms)
ITOCHU|$14.18 (¥2,248)-1.88%▼ (in JPY terms)
Honda|$10.96 (¥1,737)-2.99%▼ (in JPY terms)
Shin-Etsu|$33.04 (¥5,237)-5.28%▼ (in JPY terms)
Tokio Marine|$3.64 (¥578)+2.03%▲ (in JPY terms)
Fast Retailing|$518.70 (¥82,220)-1.38%▼ (in JPY terms)

2026-04-28 Idemitsu Kosan Co.,Ltd. “On April 28, 2026, commercial operation of an oil-based chemical recycling facility, contributing to diverse resource conservation and resource recycling through chemical recycling and the recycling of used plastics, commenced (PDF: 1.0MB). Learn more.”

2026-04-28 Idemitsu Kosan Co.,Ltd. “On April 28, 2026, commercial operation of an oil-based chemical rec … 続きを読む

2026-04-28 Otsuka Holdings Co.,Ltd. “Taiho Oncology, Taiho Pharmaceutical, and Cullinan Therapeutics have had their New Drug Application (NDA) for diparereltinib for locally advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations accepted by the U.S. FDA.”

2026-04-28 Otsuka Holdings Co.,Ltd. “Taiho Oncology, Taiho Pharmaceutical, and Cullinan Therapeutics hav … 続きを読む